Document is current
Any future updates will be listed below
-
Authors
Medehouenou, Thierry Comlan Marc http://orcid.org/0000-0001-9585-3935
Ayotte, Pierre
Carmichael, Pierre-Hugues
Kröger, Edeltraut
Verreault, René
Lindsay, Joan
Dewailly, Éric
Tyas, Suzanne L.
Bureau, Alexandre
Laurin, Danielle
-
Funding
Funding for this research was provided by:
Health Canada's National Health Research and Development Program
Canadian Institutes of Health Research
Alzheimer Society of Canada
the Canadian Dementia Knowledge Translation Network
Fonds de Recherche du Québec – Santé
Fonds de Recherche du Québec - Santé
Pfizer Canada
Merck-Frosst and Janssen-Ortho
- License Information
-
More Information
Article History
Received: 20 March 2019
Accepted: 31 May 2019
First Online: 14 June 2019
Ethics approval and consent to participate
: Each phase received approval from institutional ethics committees in participating centers. Subjects and/or family representatives gave written informed consent at each phase.Further, the measurement of biomarkers was approved by the ethic committee of the CHU de Québec, Québec, Canada.
: Not applicable.
